The University of Kentucky's Center for Clinical and Translational Science has landed a $33.9 million grant from the National Institutes of Health, money that will fund a new push to get medical research out of the lab and into the hands of patients faster. Part of that effort includes a planned study in four rural Kentucky counties aimed at treating hepatitis C the same day someone tests positive.
According to WKYT, the grant will help UK researchers improve how medical discoveries are translated into patient care. The planned HEAT study will focus on Breathitt, Knott, Lee and Owsley counties, where the research team will work with local health departments to test what the station describes as a low-barrier approach to hepatitis C care. For people who test positive for active infection, the station reports the goal is to complete assessment and hand over a full course of medication that same day, rather than requiring patients to navigate a longer, multi-step process.
A Two-Decade-Old Research Engine Gets New Fuel
The CCTS was founded in 2006 with the mission of accelerating discoveries that improve health, according to UKNow. Per the center's own quick-facts page, it offers services and resources to support research from study design all the way through study close-out, alongside education and training programs. The center has funded 300 pilot awards since its first CTSA funding in 2011, the same source notes.
Exactly how many of these federal Clinical and Translational Science Awards UK has now collected depends on which account you read. The WKYT report states that UK has received four consecutive CTSA awards since 2011, totaling $97.2 million. The center's own quick-facts page, however, says it has received two Clinical and Translational Science Awards from NCATS at NIH. The two sources do not reconcile the difference.
Where Kentucky Fits Among a Shrinking National Pool
The station's report places the University of Kentucky among 65 institutions nationwide that currently hold a CTSA. That figure differs somewhat from a separate NIH description noting that more than 60 leading medical institutions receive CTSA Program funding, per the National Center for Advancing Translational Sciences’ own page. A 2021 UKNow report on an earlier award, a $23.5 million grant that cycle, had called it the center's third successful CTSA competition and put UK's continuous CTSA funding since 2011 at $65.4 million at that time, with the center's pilot funding having yielded a 20-fold return on investment as of that report.
UK is not the only university using this federal funding mechanism to chase rural health gaps. Penn State's Clinical and Translational Science Institute recently received a seven-year, $28.2 million NIH grant of its own, intended to develop programs reaching communities with limited access to health care and research opportunities, including the use of AI and biomedical data sciences, according to Penn State.
Back in eastern Kentucky, the open question is simply what comes next. The dossier of available reporting describes the planned counties and the same-day treatment goal for the HEAT study, but does not yet detail when the work will begin, how many patients might be enrolled, or what results it produces. For now, the $33.9 million award gives UK's translational science center the funding to try, with four counties in the Appalachian foothills set to be the testing ground.
